The "Silent Partner" in a Breakthrough Cancer Therapy
A small biotech company in Europe developed a promising new cancer therapy. They needed to conduct a multi-center clinical trial across several European countries, but they lacked the internal resources to manage the complex translation requirements. We stepped in as their "silent partner," providing seamless translation of all trial materials, from the initial protocol to the final patient-reported outcomes. The result? The trial was completed on time and within budget, and the therapy is now saving lives around the world. What makes this story special is that we became an extension of their team, working closely with their scientists and clinicians to ensure that every translation was not only accurate but also sensitive to the needs of the patients involved. We celebrated their success as if it were our own.
"Working with WeMavin has significantly streamlined our regulatory submissions process." – Dr. Chang, PPD
"Their expertise in medical device translation has been invaluable to our global expansion." – Mr. Lee, PM, Mindray
Other Cases
WeMavin Helps Galaxy Entertainment Group Craft the Language of Five-Star Luxury
When a guest steps into The Ritz-Carlton, Banyan Tree, or JW Marriott, they expe......
WeMavin Brings Translation Clarity to Complex Vision Technology
For a company at the cutting edge of image processing technology like IDS, clari......
WeMavin x GuliKit: Translating a Revolution in Gaming Hardware Accurately Conveying Groundbreaking Technology to a Global Audience
When you are the company that introduced the world to drift-free Hall Effect ele......